| Host: |
Rabbit |
| Applications: |
WB/ELISA |
| Reactivity: |
Human/Rat/Mouse |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Rabbit polyclonal antibody anti-von Willebrand factor A domain-containing protein 5A (371-420 aa) is suitable for use in Western Blot and ELISA research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
Liquid in PBS containing 50% Glycerol, 0.5% BSA and 0.02% Sodium Azide. |
| Purification: |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Concentration: |
1 mg/mL |
| Dilution Range: |
WB 1:500-1:2000ELISA 1:20000 |
| Storage Instruction: |
Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Gene Symbol: |
VWA5A |
| Gene ID: |
4013 |
| Uniprot ID: |
VMA5A_HUMAN |
| Immunogen Region: |
371-420 aa |
| Specificity: |
BCSC-1 Polyclonal Antibody detects endogenous levels of BCSC-1 protein. |
| Immunogen: |
The antiserum was produced against synthesized peptide derived from the human LHR2A at the amino acid range 371-420 |
| Function | May play a role in tumorigenesis as a tumor suppressor. Altered expression of this protein and disruption of the molecular pathway it is involved in, may contribute directly to or modify tumorigenesis. |
| Protein Name | Von Willebrand Factor A Domain-Containing Protein 5aBreast Cancer Suppressor Candidate 1Bcsc-1Loss Of Heterozygosity 11 Chromosomal Region 2 Gene A Protein |
| Alternative Antibody Names | Anti-Von Willebrand Factor A Domain-Containing Protein 5a antibodyAnti-Breast Cancer Suppressor Candidate 1 antibodyAnti-Bcsc-1 antibodyAnti-Loss Of Heterozygosity 11 Chromosomal Region 2 Gene A Protein antibodyAnti-VWA5A antibodyAnti-BCSC1 antibodyAnti-LOH11CR2A antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
